Friday, April 3, 2020

Intranasal COVID-19 vaccine: Bharat Biotech ties up with FluGen, UW-Madison virologists

Intranasal COVID-19 vaccine: Bharat Biotech ties up with FluGen, UW-Madison virologists CoroFlu could be in human clinical trials by fall (September-December) of 2020, Bharat Biotech statement said.

from Moneycontrol Business News https://ift.tt/2Jz4bQB

No comments:

Post a Comment

GMR Airports shares rise 3% as company swings to black with Rs 202 crore profit in Q3

GMR Airports share price: GMR Airports shares gained 3% on news of significant profit for Q3 FY25, driven by increased passenger traffic and...